Aetna Inc. (NYSE:AET) had its price target raised by investment analysts at Royal Bank Of Canada from $162.00 to $171.00 in a report released on Friday, Marketbeat reports. The firm presently has an “outperform” rating on the stock. Royal Bank Of Canada’s price objective would indicate a potential upside of 9.06% from the stock’s current price.

A number of other research firms have also recently commented on AET. Stifel Nicolaus reaffirmed a “buy” rating and set a $150.00 price target (up from $130.00) on shares of Aetna in a research note on Wednesday, May 3rd. BidaskClub cut shares of Aetna from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. UBS AG reaffirmed a “buy” rating and set a $160.00 price target (up from $147.00) on shares of Aetna in a research note on Wednesday, May 17th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $150.00 price target on shares of Aetna in a research note on Friday, May 12th. Finally, Bank of America Corporation reaffirmed a “buy” rating and set a $168.00 price target (up from $160.00) on shares of Aetna in a research note on Wednesday, May 17th. Eight analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $155.46.

Aetna (NYSE:AET) traded down 1.10% during mid-day trading on Friday, reaching $156.79. 3,112,621 shares of the company’s stock traded hands. The stock has a market capitalization of $52.01 billion, a PE ratio of 47.82 and a beta of 0.54. Aetna has a 12-month low of $104.59 and a 12-month high of $161.69. The stock has a 50-day moving average price of $153.22 and a 200-day moving average price of $137.42.

Aetna (NYSE:AET) last issued its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, topping analysts’ consensus estimates of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The business had revenue of $15.52 billion during the quarter, compared to analysts’ expectations of $15.34 billion. During the same period last year, the company posted $2.21 EPS. The business’s revenue was down 2.7% on a year-over-year basis. Equities research analysts expect that Aetna will post $9.10 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Royal Bank Of Canada Raises Aetna Inc. (NYSE:AET) Price Target to $171.00” was originally reported by American Banking News and is owned by of American Banking News. If you are reading this report on another domain, it was stolen and republished in violation of U.S. and international copyright & trademark law. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/08/06/royal-bank-of-canada-raises-aetna-inc-nyseaet-price-target-to-171-00.html.

In other news, Chairman Mark T. Bertolini sold 103,547 shares of the business’s stock in a transaction dated Wednesday, May 17th. The shares were sold at an average price of $140.79, for a total value of $14,578,382.13. Following the completion of the sale, the chairman now owns 659,888 shares in the company, valued at approximately $92,905,631.52. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Margaret M. Mccarthy sold 27,028 shares of the business’s stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the sale, the executive vice president now owns 33,563 shares of the company’s stock, valued at approximately $5,008,606.49. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.

Several large investors have recently bought and sold shares of the stock. Quadrature Capital Ltd acquired a new stake in Aetna during the fourth quarter valued at approximately $662,000. Chevy Chase Trust Holdings Inc. raised its stake in Aetna by 3.3% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 309,206 shares of the company’s stock valued at $39,439,000 after buying an additional 9,813 shares in the last quarter. Raymond James Trust N.A. raised its stake in Aetna by 8.4% in the first quarter. Raymond James Trust N.A. now owns 6,641 shares of the company’s stock valued at $847,000 after buying an additional 514 shares in the last quarter. Creative Planning raised its stake in Aetna by 13.3% in the first quarter. Creative Planning now owns 16,574 shares of the company’s stock valued at $2,114,000 after buying an additional 1,946 shares in the last quarter. Finally, Gulf International Bank UK Ltd raised its stake in Aetna by 1.3% in the first quarter. Gulf International Bank UK Ltd now owns 109,635 shares of the company’s stock valued at $13,983,000 after buying an additional 1,450 shares in the last quarter. Institutional investors and hedge funds own 91.72% of the company’s stock.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Analyst Recommendations for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.